These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

525 related articles for article (PubMed ID: 29147991)

  • 21. Microbial monotherapy with
    Mangalam AK; Murray J
    Expert Rev Neurother; 2019 Jan; 19(1):45-53. PubMed ID: 30513004
    [No Abstract]   [Full Text] [Related]  

  • 22. Targeting gut microbiota: new therapeutic opportunities in multiple sclerosis.
    Kujawa D; Laczmanski L; Budrewicz S; Pokryszko-Dragan A; Podbielska M
    Gut Microbes; 2023 Dec; 15(2):2274126. PubMed ID: 37979154
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Breaking down the gut microbiome composition in multiple sclerosis.
    Budhram A; Parvathy S; Kremenchutzky M; Silverman M
    Mult Scler; 2017 Apr; 23(5):628-636. PubMed ID: 27956557
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gut dysbiosis and multiple sclerosis.
    Noto D; Miyake S
    Clin Immunol; 2022 Feb; 235():108380. PubMed ID: 32169440
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Multiple sclerosis patients have a distinct gut microbiota compared to healthy controls.
    Chen J; Chia N; Kalari KR; Yao JZ; Novotna M; Paz Soldan MM; Luckey DH; Marietta EV; Jeraldo PR; Chen X; Weinshenker BG; Rodriguez M; Kantarci OH; Nelson H; Murray JA; Mangalam AK
    Sci Rep; 2016 Jun; 6():28484. PubMed ID: 27346372
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Review: The Nutritional Management of Multiple Sclerosis With Propionate.
    Tobin D; Vige R; Calder PC
    Front Immunol; 2021; 12():676016. PubMed ID: 34394076
    [TBL] [Abstract][Full Text] [Related]  

  • 27. The gut microbiome: a key player in the complexity of amyotrophic lateral sclerosis (ALS).
    Boddy SL; Giovannelli I; Sassani M; Cooper-Knock J; Snyder MP; Segal E; Elinav E; Barker LA; Shaw PJ; McDermott CJ
    BMC Med; 2021 Jan; 19(1):13. PubMed ID: 33468103
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The Role of Gut Dysbiosis and Potential Approaches to Target the Gut Microbiota in Multiple Sclerosis.
    Ladakis DC; Bhargava P
    CNS Drugs; 2023 Feb; 37(2):117-132. PubMed ID: 36690786
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Perturbed Microbiota/Immune Homeostasis in Multiple Sclerosis.
    Sterlin D; Larsen M; Fadlallah J; Parizot C; Vignes M; Autaa G; Dorgham K; Juste C; Lepage P; Aboab J; Vicart S; Maillart E; Gout O; Lubetzki C; Deschamps R; Papeix C; Gorochov G
    Neurol Neuroimmunol Neuroinflamm; 2021 Jul; 8(4):. PubMed ID: 33975914
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Using data science for medical decision making case: role of gut microbiome in multiple sclerosis.
    Hasic Telalovic J; Music A
    BMC Med Inform Decis Mak; 2020 Oct; 20(1):262. PubMed ID: 33046051
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Manipulation of Gut Microbiota Influences Immune Responses, Axon Preservation, and Motor Disability in a Model of Progressive Multiple Sclerosis.
    Mestre L; Carrillo-Salinas FJ; Mecha M; Feliú A; Espejo C; Álvarez-Cermeño JC; Villar LM; Guaza C
    Front Immunol; 2019; 10():1374. PubMed ID: 31258540
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Gut microbiome and multiple sclerosis: New insights and perspective.
    Esmaeil Amini M; Shomali N; Bakhshi A; Rezaei S; Hemmatzadeh M; Hosseinzadeh R; Eslami S; Babaie F; Aslani S; Torkamandi S; Mohammadi H
    Int Immunopharmacol; 2020 Nov; 88():107024. PubMed ID: 33182024
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Multiple Sclerosis-Associated Gut Microbiome in the Israeli Diverse Populations: Associations with Ethnicity, Gender, Disability Status, Vitamin D Levels, and Mediterranean Diet.
    Nitzan Z; Staun-Ram E; Volkowich A; Miller A
    Int J Mol Sci; 2023 Oct; 24(19):. PubMed ID: 37834472
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Diet-microbiome-immune interplay in multiple sclerosis: Understanding the impact of phytoestrogen metabolizing gut bacteria.
    Lehman PC; Ghimire S; Price JD; Ramer-Tait AE; Mangalam AK
    Eur J Immunol; 2023 Nov; 53(11):e2250236. PubMed ID: 37673213
    [TBL] [Abstract][Full Text] [Related]  

  • 35. The gut microbiome and microbial translocation in multiple sclerosis.
    Mirza A; Mao-Draayer Y
    Clin Immunol; 2017 Oct; 183():213-224. PubMed ID: 28286112
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serotonin: A mediator of the gut-brain axis in multiple sclerosis.
    Malinova TS; Dijkstra CD; de Vries HE
    Mult Scler; 2018 Aug; 24(9):1144-1150. PubMed ID: 29117778
    [TBL] [Abstract][Full Text] [Related]  

  • 37. [Multiple sclerosis and microbiota. From genome to metagenome?].
    Hohlfeld R; Wekerle H
    Nervenarzt; 2015 Aug; 86(8):925-33. PubMed ID: 26099498
    [TBL] [Abstract][Full Text] [Related]  

  • 38. The Gut Microbiota and Pediatric Multiple Sclerosis: Recent Findings.
    Tremlett H; Waubant E
    Neurotherapeutics; 2018 Jan; 15(1):102-108. PubMed ID: 28940049
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Gut commensals, dysbiosis, and immune response imbalance in the pathogenesis of multiple sclerosis.
    Brown J; Quattrochi B; Everett C; Hong BY; Cervantes J
    Mult Scler; 2021 May; 27(6):807-811. PubMed ID: 32507072
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Multiple Sclerosis: Melatonin, Orexin, and Ceramide Interact with Platelet Activation Coagulation Factors and Gut-Microbiome-Derived Butyrate in the Circadian Dysregulation of Mitochondria in Glia and Immune Cells.
    Anderson G; Rodriguez M; Reiter RJ
    Int J Mol Sci; 2019 Nov; 20(21):. PubMed ID: 31694154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 27.